🔎 Trials Near Me

Hjem › Akut myelogen leukemi › California › Mountain View

Kliniske studier for Akut myelogen leukemi i Mountain View, CA

19 studier for Akut myelogen leukemi søker deltakere på steder i og rundt Mountain View (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

RekruttererFase 1
  • Lucile Packard Children's Hospital /ID# 276015, Palo Alto · 5 mi unna
6 Months – 17 Years · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07306832

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

RekruttererFase 1
  • Stanford Health Care, Stanford · 5 mi unna
Alder 12 til 78 · Alle kjønn · Oppdatert 29. sep. 2026 · NCT03802695

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

RekruttererFase 3
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi unna
6 Months – 21 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

RekruttererFase 2
  • Stanford Cancer Institute, Stanford · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT04996875

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

RekruttererFase 1/2
  • Lucile Packard Children's Hospital Stanford University, Palo Alto · 5 mi unna
Opp til 22 år · Alle kjønn · Oppdatert 25. aug. 2026 · NCT04726241

Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

RekruttererFase 1
  • Lucille Packard Children's Hospital of Stanford University, Palo Alto · 5 mi unna
18 Months – 39 Years · Alle kjønn · Oppdatert 21. aug. 2026 · NCT07573111

TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

RekruttererFase 1
  • Stanford University, Palo Alto · 5 mi unna
Alder 18 til 80 · Alle kjønn · Oppdatert 17. aug. 2026 · NCT07302776

Niclosamide in Pediatric Patients With Relapsed and Refractory AML

RekruttererFase 1
  • Stanford University, Palo Alto · 5 mi unna
Alder 2 til 25 · Alle kjønn · Oppdatert 12. aug. 2026 · NCT05188170

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

RekruttererObservasjonsstudie
  • Stanford University Medical Center, Stanford · 5 mi unna
Alle aldre · Alle kjønn · Oppdatert 6. jul. 2026 · NCT01351545

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

RekruttererFase 1
  • Stanford University, Palo Alto · 5 mi unna
Alder 18 til 70 · Alle kjønn · Oppdatert 23. jun. 2026 · NCT06551584

Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy

RekruttererFase 1
  • Stanford University, Stanford · 5 mi unna
Opp til 21 år · Alle kjønn · Oppdatert 22. apr. 2026 · NCT05101551

Tagraxofusp and Low-Intensity Chemotherapy for CD123-Positive Relapsed or Refractory AML

RekruttererFase 1/2
  • Stanford University, Palo Alto · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 14. apr. 2026 · NCT06561152

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

RekruttererFase 1/2
  • Stanford University, Palo Alto · 5 mi unna
Alder 12 og eldre · Alle kjønn · Oppdatert 24. mar. 2026 · NCT04988555

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

RekruttererFase 1
  • Stanford Medical Center, Palo Alto · 5 mi unna
Alder 12 og eldre · Alle kjønn · Oppdatert 16. mar. 2026 · NCT06994676

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

RekruttererFase 1
  • Stanford University, Stanford · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 9. feb. 2026 · NCT06950034

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

RekruttererFase 1
  • Stanford Cancer Center, Palo Alto · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 24. sep. 2025 · NCT06501196

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

RekruttererFase 1/2
  • Stanford Cancer Center, Palo Alto · 5 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2025 · NCT03850574

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

RekruttererFrivillige helsepersonell ønskes velkommen
  • Stanford University, Stanford · 5 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 25. jul. 2025 · NCT05237258

Akut myelogen leukemi-studier i andre byer

Andre studier i Mountain View

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.